7th Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; and.
Department of Burn and Plastic Surgery, the Fourth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, China.
J Craniofac Surg. 2022;33(5):1619-1625. doi: 10.1097/SCS.0000000000008470. Epub 2022 Jan 18.
Pathological scars are dermal fibroproliferative disorders due to rapid inflammatory response after dermal injury. The altered metabolites could reflect pathophysiological changes directly. However, it has not cleared how the metabolites change scars.
To explore new ideas of pathological scars from the altered metabolites by using ultra-performance liquid chromatography coupled to tandem mass spectrometry and identifying the key genes.
Keloid (KS, n = 10), hypertrophic scar (HS, n = 10), and normal skin (NS, n = 10) were collected. Ultra-performance liquid chromatography coupled to tandem mass spectrometry was used to identify and characterize metabolites. Differential metabolites were analyzed by orthogonal partial least square discriminant analysis and Student t test. The key pathways were analyzed via Kyoto Encyclopedia of Genes and Genomes, and the related enzymes were verified by real-time Polymerase Chain Reaction, both in tissues and their dermal fibroblasts.
Two hundred fourteen metabolites were detected in total, mostly were fatty acids and amino acids. In the KS and NS groups, 65 different metabolites were screened ( P < 0.05), and the polyunsaturated fatty acids (PUFAs) metabolism and butyric acid in keloid should be concerned. The messenger Ribonucleic Acid expression of fatty acid desaturase 1 and fatty acid desaturase 2, which are the key enzyme of PUFA metabolism, were lower in KS and keloid-derived fibroblasts, P < 0.05. In HS group, 17 metabolites were significantly different and branched chain amino acids degradation was the key pathway. Moreover, branched chain keto acid dehydrogenase E1 subunit alpha was lower expressed in HS and their fibroblasts compared with NS, P < 0.05.
Polyunsaturated fatty acids and butyric acid may be associated with the generation of keloids. The pathogenesis of hypertrophic scars may be involved in branched chain amino acids degradation, which is worth paying attention to.
病理性瘢痕是真皮纤维组织过度增生性疾病,由于真皮损伤后炎症反应迅速。改变的代谢物可以直接反映病理生理变化。然而,代谢物如何改变瘢痕尚不清楚。
通过超高效液相色谱串联质谱法(UPLC-MS/MS)鉴定和识别关键基因,从改变的代谢物中探索病理性瘢痕的新观点。
收集瘢痕疙瘩(KS)(n=10)、增生性瘢痕(HS)(n=10)和正常皮肤(NS)(n=10)。采用 UPLC-MS/MS 鉴定和描述代谢物。采用正交偏最小二乘判别分析和 Student t 检验分析差异代谢物。通过京都基因与基因组百科全书(KEGG)分析关键通路,并通过实时聚合酶链反应(PCR)在组织及其真皮成纤维细胞中验证相关酶。
共检测到 214 种代谢物,主要为脂肪酸和氨基酸。KS 和 NS 组共筛选出 65 种不同的代谢物(P<0.05),应关注多不饱和脂肪酸(PUFA)代谢和瘢痕疙瘩中的丁酸。KS 和瘢痕疙瘩衍生的成纤维细胞中,PUFA 代谢的关键酶脂肪酸去饱和酶 1 和脂肪酸去饱和酶 2 的信使核糖核酸(mRNA)表达较低,P<0.05。HS 组有 17 种代谢物明显不同,支链氨基酸降解是关键途径。此外,HS 及其成纤维细胞中支链酮酸脱氢酶 E1 亚基α的表达低于 NS,P<0.05。
多不饱和脂肪酸和丁酸可能与瘢痕疙瘩的发生有关。增生性瘢痕的发病机制可能涉及支链氨基酸降解,值得关注。